Flu season: The flu shot and what parents need to know now
The 2014-15 flu season is here, and it’s reached epidemic proportions. This season’s strain appears particularly nasty. About half of the United States is contending with high levels of flu activity, which means an onslaught of symptoms like fever, runny or stuff nose, cough and sore throat. Massachusetts has not been hit as hard as some other areas of the country. But the relative lull in flu activity might be the calm before the storm. The flu season will last for several more weeks, especially in areas that have not yet seen significant activity, according to the Centers for Disease Control and Prevention (CDC). Got questions about the flu? We have answers. Is the flu shot effective? Although the flu shot does not cover the H3N2 strain that is causing about 90 percent of flu cases this season, it does provide partial protection from the virus. It may reduce severe outcomes like hospitalization and death. Even if you and your child have not yet been vaccinated, it is a good idea to get the shot as part of your family’s flu defense. What can I do to keep my family healthy and avoid the flu? First, make sure everyone in your family older than 6 months of age gets the flu shot every year, says Ronald Samuels, MD, MPH, associate medical director of Boston Children’s Primary Care Center. Other basic precautions include: Wash your hands often with soap and water for 20 seconds. (Encourage your kids to sing “Happy Birthday” twice as they lather...
Authors: Rombauts A, Abelenda-Alonso G, Cuervo G, Gudiol C, Carratalà J Abstract INTRODUCTION: Despite adequate antibiotic coverage, community-acquired pneumonia (CAP) remains a leading cause of hospitalization and mortality worldwide. It induces both a local pulmonary and a systemic inflammatory response, particularly significant in severe cases. The intensity of the dysregulated host response varies from patient to patient and has a negative impact on survival and other outcomes. AREAS COVERED: This comprehensive review summarizes the pathophysiological aspects of the inflammatory response in CAP, brie...
CONCLUSIONS: Xyloglucan/gelose plus ORS was effective and safe in treating acute diarrhea in children. PMID: 33028102 [PubMed - as supplied by publisher]
CONCLUSIONS: Considering the low number of university students disclosing sexual assaults to health professionals or support services, the results of this survey suggest more work is needed to facilitate greater disclosures to health professionals enabling victims to access the services they need regardless of alcohol use. PMID: 33032303 [PubMed - in process]
Publication date: October 2020Source: Brain, Behavior, and Immunity, Volume 89Author(s): E.K. Grantham, A.S. Warden, G.S. McCarthy, A. DaCosta, S. Mason, Y. Blednov, R.D. Mayfield, R.A. Harris
CONCLUSION: When gastroenterologists encounter NAFLD/NASH patients, serum CK should be verified. If hyperCKemia, frontal baldness, a hatched face, history of cataract surgery, and grip myotonia are noted, the possibility of MD may be considered. PMID: 33033573 [PubMed]
Authors: Tamai H, Shingaki N, Ida Y, Shimizu R, Maeshima S, Okamura J, Kawashima A, Nakao T, Hara T, Matsutani H, Nishikawa I, Higashi K Abstract BACKGROUND: Although clinical use of sofosbuvir plus ribavirin has been approved for patients infected with genotype 2 hepatitis C virus, patients ≥ 75-years-old have not been included in previous clinical trials. AIM: To evaluate the real-world safety and efficacy of sofosbuvir plus ribavirin for elderly patients (≥ 75-years-old) compared to nonelderly patients, we conducted a post-marketing prospective cohort study. METHODS: We treated 265 patients with ge...
Authors: Arab JP, Dirchwolf M, Álvares-da-Silva MR, Barrera F, Benítez C, Castellanos-Fernandez M, Castro-Narro G, Chavez-Tapia N, Chiodi D, Cotrim H, Cusi K, de Oliveira CPMS, Díaz J, Fassio E, Gerona S, Girala M, Hernandez N, Marciano S, Masson W, Mendez-Sanchez N, Leite N, Lozano A, Padilla M, Panduro A, Paraná R, Parise E, Perez M, Poniachik J, Restrepo JC, Ruf A, Silva M, Tagle M, Tapias M, Torres K, Vilar-Gomez E, Costa Gil JE, Gadano A, Arrese M Abstract Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chr...
CONCLUSION: The ultrasonography measure of right liver lobe diameter by itself can reliably identify patients with NAFLD with a good sensitivity and specificity, however, this can be improved by adding the LAP mathematical index in our population. PMID: 33031969 [PubMed - as supplied by publisher]
Emergency-use authorizations, a formerly obscure corner of regulatory law, have become a centerpiece of the government ’s response to the pandemic.
The use of an immune-system stimulant harvested from shark liver oil in the development of some coronavirus vaccines has animal conservationists pressing for alternatives.(Image credit: Reinhard Dirscherl/ullstein bild via Getty Images)
More News: Alcoholism | Centers for Disease Control and Prevention (CDC) | Children | Computers | Cough | ENT & OMF | Epidemics | Epidemiology | Eyes | H3N2 | Hospitals | Oseltamivir | Pediatrics | Pneomococcal Vaccine | Pneumonia | Primary Care | Relenza | Sore Throat | Tamiflu | Teaching | Universities & Medical Training | Vaccines | Zanamivir